195 results on '"Canti, Valentina"'
Search Results
2. Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus
3. Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors.
4. One-year mental health outcomes in a cohort of COVID-19 survivors
5. Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases
6. Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment
7. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
8. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospective Italian P-RHEUM.it study
9. P138 Pregnancy outcomes in SLE patients treated with belimumab: the Italian experience
10. Corrigendum to “Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group” [Placenta. 136 (2023 Apr 3) 29–34]
11. Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group
12. Choroid Plexus Enlargement In Systemic Lupus Erythematosus: Relationship With Auto-Antibody Status And Neuropsychiatric Involvement (P10-3.016)
13. Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)
14. High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
15. Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
16. Treating unexplained recurrent pregnancy loss based on lessons learned from obstetric antiphospholipid syndrome and inherited thrombophilia: A propensity-score adjusted retrospective study
17. Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report
18. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors.
19. Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
20. Beta-adducin and sodium–calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis
21. Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
22. One-year mental health outcomes in a cohort of COVID-19 survivors
23. Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus
24. Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
25. Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry
26. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
27. Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al.
28. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
29. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors
30. Low-molecular-weight heparin for prevention of unexplained recurrent miscarriage
31. Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology
32. Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes
33. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
34. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
35. Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort
36. Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study
37. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case–control study
38. Quantitative MRI adds to neuropsychiatric lupus diagnostics
39. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study
40. Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment
41. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting
42. Diffuse cutaneous manifestation in a new mother with COVID‐19 (SARS‐Cov‐2)
43. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives
44. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry
45. Quantitative MRI adds to neuropsychiatric lupus diagnostics.
46. EEcacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus
47. Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus
48. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study
49. SAT0204 LUPUS LOW-DISEASE ACTIVITY STATE VS SLE RESPONDER INDEX IN A “REAL-LIFE” SETTING
50. SAT0177 CLINICAL AND EPIDEMIOLOGICAL RELEVANCE OF ALLERGY IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN OBSERVATIONAL STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.